Marshall Wace, LLP Amedisys Inc Transaction History

Marshall Wace, LLP

$78.4 Billion
Q4 2024

A detailed history of Marshall Wace, LLP transactions in Amedisys Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 194,603 shares of AMED stock, worth $17.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

194,603

Previous 341,946 43.09%

Holding current value

$17.9 Million

Previous $33 Million 46.46%

% of portfolio

0.02%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$83.78 - $97.71 $12.3 Million - $14.4 Million	-147,343 Reduced 43.09%	194,603 $17.7 Million
Q3 2024 Nov 14, 2024	BUY	$96.5 - $98.45 $7.12 Million - $7.27 Million	73,824 Added 27.53%	341,946 $33 Million
Q2 2024 Aug 14, 2024	SELL	$90.4 - $96.77 $2.11 Million - $2.26 Million	-23,381 Reduced 8.02%	268,122 $24.6 Million
Q1 2024 May 15, 2024	SELL	$92.15 - $95.24 $10.6 Million - $11 Million	-115,125 Reduced 28.31%	291,503 $26.9 Million
Q4 2023 Feb 14, 2024	BUY	$91.15 - $95.89 $8.43 Million - $8.87 Million	92,485 Added 29.44%	406,628 $38.7 Million
Q3 2023 Nov 14, 2023	BUY	$89.84 - $94.08 $19.8 Million - $20.7 Million	219,852 Added 233.16%	314,143 $29.3 Million
Q2 2023 Aug 14, 2023	BUY	$73.99 - $92.6 $221,526 - $277,244	2,994 Added 3.28%	94,291 $8.62 Million
Q1 2023 May 15, 2023	BUY	$69.79 - $100.33 $6.37 Million - $9.16 Million	91,297 New	91,297 $6.71 Million
Q4 2021 Feb 14, 2022	SELL	$136.32 - $184.41 $1.7 Million - $2.3 Million	-12,477 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$149.1 - $270.32 $1.86 Million - $3.37 Million	12,477 New	12,477 $1.86 Million
Q2 2021 Aug 13, 2021	SELL	$238.97 - $288.5 $828,986 - $1 Million	-3,469 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$236.62 - $314.16 $2.76 Million - $3.66 Million	-11,656 Reduced 77.06%	3,469 $919,000
Q4 2020 Feb 16, 2021	SELL	$231.3 - $293.33 $773,698 - $981,188	-3,345 Reduced 18.11%	15,125 $4.44 Million
Q3 2020 Nov 16, 2020	SELL	$199.22 - $248.1 $1.5 Million - $1.87 Million	-7,542 Reduced 28.99%	18,470 $4.37 Million
Q2 2020 Aug 13, 2020	BUY	$169.77 - $213.81 $4.42 Million - $5.56 Million	26,012 New	26,012 $5.17 Million
Q1 2020 May 15, 2020	SELL	$137.21 - $202.02 $4.52 Million - $6.66 Million	-32,963 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$122.85 - $167.13 $6.08 Million - $8.27 Million	-49,482 Reduced 60.02%	32,963 $5.5 Million
Q3 2019 Nov 14, 2019	SELL	$117.97 - $137.89 $19 Million - $22.2 Million	-161,263 Reduced 66.17%	82,445 $10.8 Million
Q2 2019 Aug 14, 2019	BUY	$108.08 - $129.67 $2.51 Million - $3.01 Million	23,205 Added 10.52%	243,708 $29.6 Million
Q1 2019 May 14, 2019	BUY	$110.76 - $138.73 $18.1 Million - $22.7 Million	163,842 Added 289.16%	220,503 $27.2 Million
Q4 2018 Feb 14, 2019	BUY	$98.2 - $140.23 $5.56 Million - $7.95 Million	56,661 New	56,661 $6.64 Million

Others Institutions Holding AMED

# of Institutions

328

Shares Held

29.4M

Call Options Held

802K

Put Options Held

3.74M

View Full List

About AMEDISYS INC

Ticker AMED
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 32,492,000
Market Cap $2.98B
Description
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...

More about AMED

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Amedisys Inc Transaction History